Biotechnology News

The global market for Proteomics is forecast to reach US$30.5 billion by the year 2024, driven by the technology’s growing significance in public health and nutrition research; Growing focus of the medical and research community in discovering new protein biomarkers for different disease conditions; increasing R&D funding from various governments for proteomics research, extensive use in analyzing target proteins for diagnosing various diseases, and growing emphasis on personalized medicine. Poised to benefit are all areas of proteomics research including protein separation, protein identification, protein quantification, protein sequence analysis, structural proteomics, interaction proteomics, protein modification and cellular proteomics. The market is also benefitting from increasing penetration of technologies for comprehensive analysis of proteins, such as ElectroSpray Ionization-Liq..

The global market for Automated and Rapid Microbiological Tests is forecast to reach US$6.5 billion by 2022, driven by the increasing penetration of laboratory automation technologies in non-clinical applications. Stringent safety regulations governing processed foods ranks as a key factor playing an instrumental role in pushing up demand for these tests in non-clinical applications. In clinical applications, rapid pathogen identification is gaining in importance due to the increase in outbreak of new diseases caused by mutant drug resistant microorganisms. Rapid and reliable testing is critical in preventing disease progression and spread, enhancing the accuracy and efficiency of medical treatment decisions, enabling administration of appropriate antimicrobial therapy, reducing morbidity rates and lowering associated costs. The United States represents the largest market worldwide suppo..

As a Wiser World Looks to Make a Strong Sustainable Recovery From COVID-19, Synthetic Biology to Receive New Opportunities for Growth. Market to Reach $33.2 Billion. The global market for Synthetic Biology is projected to reach US$33.2 billion by the year 2027, trailing a post COVID-19 CAGR of 25.2%, over the analysis period 2020 through 2027. With humans continuing their mindless plunder of the planet, natural habitat destruction and climate change has already set the stage for an era of pandemics. Animal-borne infectious diseases will continue to rise in the coming years, as human become the new host for displaced animal viruses. The current scenario has amplified the urgency to address environmental issues & ensure strict compliance among polluting businesses. Synthetic biology unfolds a new scientific era, in which synthetic organisms can be created to serve different purposes. Th..

The global market for Biochips is projected to reach US$31.3 billion by 2024, driven by developments in bioinformatics; progressive improvements in technology standardization; and increasing application of genomics and proteomics in cancer diagnostics. Broader market forces positively influencing growth in the market include growing burden of diseases testing, urgent need for advanced diagnostic solutions, advancements in semiconductor solutions for healthcare including microelectronics and biosensors; and growing interest in the value offered by fully integrated biochip platforms for advanced healthcare; strong market for proteomics and genomics; growing commercial opportunity for personalized medicine and the ensuing demand for DNA biochips; emphasis on pharmacogenomic strategies in drug safety and the resulting demand for microfluidic and lab-on-a-chip devices, and new uses of biochip..

Global Market for Biogas Plants to Reach $6.8 Billion by 2027 The global market for Biogas Plants is projected to reach US$6.8 billion by the year 2027, trailing a post COVID-19 CAGR of 6.7% over the analysis period 2020 through 2027. The severe impact of COVID-19 pandemic in areas with high level of air pollution has prompted the researcher community to explore the direct link between severity of the infection and air quality. Various scientists have indicated a perceived association between spread of the virus along with fatality rates and air pollution. Poor air quality adversely affects human health and leaves people susceptible to various infectious diseases including COVID-19. In 2020, medical conditions associated with air pollution are estimated to claim around 7 million lives globally. Air pollution is a key contributor to various medical conditions including heart disease,..

The global market for Molecular Cytogenetics is projected to reach US$2.3 billion by 2022, driven by the rising demand for rapid and accurate diagnostic techniques capable of detecting chromosomal anomalies that predispose patient groups to various diseases. Given the epidemic spread of cancer worldwide, there is greater need for better understanding the relation between certain chromosomal anomalies and cancer development and progression. The scenario is driving demand for Multiplex Fluorescence in situ Hybridization (M-FISH) in clinical cytogenetics and research applications. Few of the benefits offered by molecular cytogenetics in cancer diagnosis and treatment include early identification of premalignant lesions; improved classification of tumors; reliable identification of tumor-specific chromosomal abnormalities; enables the development of tumor-specific genetic markers for bone an..

The global market for Biofuel Enzymes is projected to exceed US$1.3 billion by 2022, driven by the growing prominence of biofuels in the global energy mix, and superiority of enzyme-based biofuel production over conventional methods such as fermentation/transesterification. The growing global demand for biofuels and the parallel rise in environmental concerns raised by increased production activities is benefiting the use of biofuel enzymes which help improve the efficiency of production processes while simultaneously reducing carbon footprint. Production by enzymatic catalyzed processes is less energy intensive, more efficient in producing high quality biodiesel and also allows for the use of unrefined feedstock. The United States and Europe represent the largest markets worldwide supported by factors such as implementation of regulations for curbing fossil fuel use; policies that encou..

The global market for Biopharmaceutical Bioseparation Systems is projected to reach US$11.4 billion by 2024, driven by the growing demand for biopharmaceuticals comprising biosimilars and biologics; increased drug development activity; continuous technology advancements; growing focus on enhancing efficiencies in biopharmaceutical downstream processing; government initiatives aimed at increasing awareness; and growing use of single-use/disposable instruments. Patent expiries of biological drugs and the resulting rise of biosimilars is driving the need for the expansion and establishment of new biomanufacturing facilities. Few of the factors driving demand for biologics include the need for more effective medical therapies; reduced side-effects and higher safety profile; aging population and a parallel rise in chronic disease burden; among others. The emergence of new biological drugs suc..

Most R&D budgets which are so vital for innovation are largely dependent upon financial support from governments. Healthy financial performance of companies also determines the extent of willingness to reinvest earnings into R&D and new product development. The COVID-19 induced recession has now cast serious questions on the ability of governments and companies to earmark financial commitments in times of crisis. Academic and industrial research is expected to come under the yoke as immediate focus on surviving the downturn lowers the appetite for both indigenous innovation and international collaboration. Lockdowns imposed in countries worldwide has shutdown laboratories, stifled supply chains and slowed down R&D projects in companies. The modern innovation ecosystem is tightly integrated and interconnected with multiple players in the industry. This close R&D cooperation is expected to..

Segments covered: Type (Manual, Automated); Application (Peripheral Blood, Bone Marrow, Umbilical Cord, Adipose Tissue, Other Applications); End-Use (Biotech & Biopharma Companies, Research Institutes, Other End-Uses)Regions covered: World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Global Cannabis Testing Market to Reach $2 Billion by 2027Amid the COVID-19 crisis, the global market for Cannabis Testing estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$2 Billion by 2027, growing at aCAGR of 9.6% over the period 2020-2027. Products, one of the segments analyzed in the report, is projected to record 8.7% CAGR and reach US$1.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Software (Cannabis LIMS) segment is readjusted to a revised 11.2% CAGR for the next 7-year period.The U.S. Market is Estimated at $314.2 Million, While China is Forecast to Grow at 9% CAGRThe Cannabis Testing market in the U.S. is estimated at US$314.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a project..

Global 2D Chromatography Market to Reach $50.9 Million by 2027Amid the COVID-19 crisis, the global market for 2D Chromatography estimated at US$33.2 Million in the year 2020, is projected to reach a revised size of US$50.9 Million by 2027, growing at aCAGR of 6.3% over the period 2020-2027. 2D Gas Chromatography, one of the segments analyzed in the report, is projected to record 6.7% CAGR and reach US$34.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the 2D Liquid Chromatography segment is readjusted to a revised 5.4% CAGR for the next 7-year period.The U.S. Market is Estimated at $9 Million, While China is Forecast to Grow at 9.7% CAGRThe 2D Chromatography market in the U.S. is estimated at US$9 Million in the year 2020. China, the world`s second largest economy, is forecast t..

Global Bioinformatics Market to Reach $21.5 Billion by 2027Amid the COVID-19 crisis, the global market for Bioinformatics estimated at US$9 Billion in the year 2020, is projected to reach a revised size of US$21.5 Billion by 2027, growing at a CAGR of 13.2% over the analysis period 2020-2027. Knowledge Management Tools, one of the segments analyzed in the report, is projected to record a 12.5% CAGR and reach US$9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bioinformatics Platforms segment is readjusted to a revised 14.4% CAGR for the next 7-year period.The U.S. Market is Estimated at $2.4 Billion, While China is Forecast to Grow at 17.3% CAGRThe Bioinformatics market in the U.S. is estimated at US$2.4 Billion in the year 2020. China, the world`s second largest economy, is f..

Global DNA Sequencing Market to Reach $28.8 Billion by 2027Amid the COVID-19 crisis, the global market for DNA Sequencing estimated at US$9.4 Billion in the year 2020, is projected to reach a revised size of US$28.8 Billion by 2027, growing at a CAGR of 17.3% over the analysis period 2020-2027. Diagnostics, one of the segments analyzed in the report, is projected to record a 17.7% CAGR and reach US$7.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Drug Discovery segment is readjusted to a revised 15.1% CAGR for the next 7-year period.The U.S. Market is Estimated at $2.8 Billion, While China is Forecast to Grow at 16.6% CAGRThe DNA Sequencing market in the U.S. is estimated at US$2.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a pr..

Global Biologics Safety Testing Market to Reach $3.3 Billion by 2027Amid the COVID-19 crisis, the global market for Biologics Safety Testing estimated at US$1.9 Billion in the year 2020, is projected to reach a revised size of US$3.3 Billion by 2027, growing at a CAGR of 8.5% over the analysis period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record a 7.8% CAGR and reach US$963.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Kits & Reagents segment is readjusted to a revised 9.1% CAGR for the next 7-year period.The U.S. Market is Estimated at $556.7 Million, While China is Forecast to Grow at 8% CAGRThe Biologics Safety Testing market in the U.S. is estimated at US$556.7 Million in the year 2020. China, the world`s second largest econo..

Global Nanobiotechnology Market to Reach $100.8 Billion by 2027Amid the COVID-19 crisis, the global market for Nanobiotechnology estimated at US$62.3 Billion in the year 2020, is projected to reach a revised size of US$100.8 Billion by 2027, growing at aCAGR of 7.1% over the period 2020-2027. Pharmaceuticals & Biotechnology Industry, one of the segments analyzed in the report, is projected to record 7.7% CAGR and reach US$68.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Medical Devices segment is readjusted to a revised 6% CAGR for the next 7-year period.The U.S. Market is Estimated at $18.4 Billion, While China is Forecast to Grow at 6.6% CAGRThe Nanobiotechnology market in the U.S. is estimated at US$18.4 Billion in the year 2020. China, the world`s second largest econom..

Global Epigenetics Market to Reach $25.6 Billion by 2027Amid the COVID-19 crisis, the global market for Epigenetics estimated at US$7.4 Billion in the year 2020, is projected to reach a revised size of US$25.6 Billion by 2027, growing at a CAGR of 19.5% over the analysis period 2020-2027. Reagents, one of the segments analyzed in the report, is projected to record a 19.9% CAGR and reach US$10.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Kits segment is readjusted to a revised 22.4% CAGR for the next 7-year period.The U.S. Market is Estimated at $2.2 Billion, While China is Forecast to Grow at 18.8% CAGRThe Epigenetics market in the U.S. is estimated at US$2.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size o..

Global Non-ionizing Radiation/EMF Detection, Measurement, and Safety Market to Reach $77.1 Billion by 2027Amid the COVID-19 crisis, the global market for Non-ionizing Radiation/EMF Detection, Measurement, and Safety estimated at US$57.2 Billion in the year 2020, is projected to reach a revised size of US$77.1 Billion by 2027, growing at a CAGR of 4.4% over the analysis period 2020-2027. Personal Monitoring Devices, one of the segments analyzed in the report, is projected to record a 4.7% CAGR and reach US$24 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Handheld Monitoring Devices segment is readjusted to a revised 4.3% CAGR for the next 7-year period.The U.S. Market is Estimated at $16.8 Billion, While China is Forecast to Grow at 4.1% CAGRThe Non-ionizing Radiation/EMF Dete..

Global Microbiome Sequencing Services Market to Reach $2.9 Billion by 2027Amid the COVID-19 crisis, the global market for Microbiome Sequencing Services estimated at US$931.8 Million in the year 2020, is projected to reach a revised size of US$2.9 Billion by 2027, growing at a CAGR of 17.8% over the analysis period 2020-2027. Synthesis, one of the segments analyzed in the report, is projected to record a 16.6% CAGR and reach US$1.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Ligation segment is readjusted to a revised 14.6% CAGR for the next 7-year period.The U.S. Market is Estimated at $275.8 Million, While China is Forecast to Grow at 17.2% CAGRThe Microbiome Sequencing Services market in the U.S. is estimated at US$275.8 Million in the year 2020. China, the world`s secon..

Global Label-free Array Systems Market to Reach $1.8 Billion by 2027Amid the COVID-19 crisis, the global market for Label-free Array Systems estimated at US$1.3 Billion in the year 2020, is projected to reach a revised size of US$1.8 Billion by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027. Surface Plasmon Resonance (SPR), one of the segments analyzed in the report, is projected to record a 5.5% CAGR and reach US$1.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bio-layer Interferometry (BLI) segment is readjusted to a revised 4.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $375.2 Million, While China is Forecast to Grow at 5.1% CAGRThe Label-free Array Systems market in the U.S. is estimated at US$375.2 Million in the year 2020. Chin..

Global Whole Exome Sequencing Market to Reach $3.5 Billion by 2027Amid the COVID-19 crisis, the global market for Whole Exome Sequencing estimated at US$1 Billion in the year 2020, is projected to reach a revised size of US$3.5 Billion by 2027, growing at a CAGR of 18.7% over the analysis period 2020-2027. Systems, one of the segments analyzed in the report, is projected to record a 17.5% CAGR and reach US$944.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Kits segment is readjusted to a revised 21.1% CAGR for the next 7-year period.The U.S. Market is Estimated at $310.8 Million, While China is Forecast to Grow at 18.5% CAGRThe Whole Exome Sequencing market in the U.S. is estimated at US$310.8 Million in the year 2020. China, the world`s second largest economy, is forecast t..

Global Human Microbiome Market to Reach $964.5 Million by 2027Amid the COVID-19 crisis, the global market for Human Microbiome estimated at US$391 Million in the year 2020, is projected to reach a revised size of US$964.5 Million by 2027, growing at a CAGR of 13.8% over the analysis period 2020-2027. Acute Diarrhea, one of the segments analyzed in the report, is projected to record a 14.9% CAGR and reach US$527 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Obesity segment is readjusted to a revised 12.6% CAGR for the next 7-year period.The U.S. Market is Estimated at $115.6 Million, While China is Forecast to Grow at 13.2% CAGRThe Human Microbiome market in the U.S. is estimated at US$115.6 Million in the year 2020. China, the world`s second largest economy, is forecast to re..

Global Industrial Microbiology Market to Reach $14.4 Billion by 2027Amid the COVID-19 crisis, the global market for Industrial Microbiology estimated at US$10.5 Billion in the year 2020, is projected to reach a revised size of US$14.4 Billion by 2027, growing at a CAGR of 4.6% over the analysis period 2020-2027. Pharmaceutical, one of the segments analyzed in the report, is projected to record a 4.2% CAGR and reach US$6.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Food & Beverage segment is readjusted to a revised 5.3% CAGR for the next 7-year period.The U.S. Market is Estimated at $3.1 Billion, While China is Forecast to Grow at 4.3% CAGRThe Industrial Microbiology market in the U.S. is estimated at US$3.1 Billion in the year 2020. China, the world`s second largest econom..

Global Agricultural Biotechnology Market to Reach $66.2 Billion by 2027Amid the COVID-19 crisis, the global market for Agricultural Biotechnology estimated at US$35.3 Billion in the year 2020, is projected to reach a revised size of US$66.2 Billion by 2027, growing at a CAGR of 9.4% over the analysis period 2020-2027. Molecular Diagnostics, one of the segments analyzed in the report, is projected to record a 10.8% CAGR and reach US$26.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Tissue Culture segment is readjusted to a revised 10.1% CAGR for the next 7-year period.The U.S. Market is Estimated at $10.5 Billion, While China is Forecast to Grow at 8.7% CAGRThe Agricultural Biotechnology market in the U.S. is estimated at US$10.5 Billion in the year 2020. China, the world`s s..

Global Life Science Instrumentation Market to Reach $86.4 Billion by 2027Amid the COVID-19 crisis, the global market for Life Science Instrumentation estimated at US$60.3 Billion in the year 2020, is projected to reach a revised size of US$86.4 Billion by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027. Research Applications, one of the segments analyzed in the report, is projected to record a 5.2% CAGR and reach US$42.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Clinical & Diagnostic Applications segment is readjusted to a revised 5.9% CAGR for the next 7-year period.The U.S. Market is Estimated at $17.8 Billion, While China is Forecast to Grow at 4.9% CAGRThe Life Science Instrumentation market in the U.S. is estimated at US$17.8 Billion in the year 20..

Global Human Embryonic Stem Cell (hESC) Research Market to Reach $1 Billion by 2027Amid the COVID-19 crisis, the global market for Human Embryonic Stem Cell (hESC) Research estimated at US$650.9 Million in the year 2020, is projected to reach a revised size of US$1 Billion by 2027, growing at a CAGR of 6.5% over the analysis period 2020-2027. Regenerative Medicine, one of the segments analyzed in the report, is projected to record a 6.6% CAGR and reach US$717.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Stem Cell Biology Research segment is readjusted to a revised 7.4% CAGR for the next 7-year period.The U.S. Market is Estimated at $192.2 Million, While China is Forecast to Grow at 6.1% CAGRThe Human Embryonic Stem Cell (hESC) Research market in the U.S. is estimated at US..

Global Biotechnology Market to Reach $832 Billion by 2027Amid the COVID-19 crisis, the global market for Biotechnology estimated at US$469.6 Billion in the year 2020, is projected to reach a revised size of US$832 Billion by 2027, growing at a CAGR of 8.5% over the analysis period 2020-2027. DNA Sequencing Market, one of the segments analyzed in the report, is projected to record a 8.8% CAGR and reach US$25.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Fermentation Market segment is readjusted to a revised 8.1% CAGR for the next 7-year period.The U.S. Market is Estimated at $126.9 Billion, While China is Forecast to Grow at 11.6% CAGRThe Biotechnology market in the U.S. is estimated at US$126.9 Billion in the year 2020. China, the world`s second largest economy, is forecast..

Global Biologics Market to Reach $505.6 Billion by 2027Amid the COVID-19 crisis, the global market for Biologics estimated at US$292.2 Billion in the year 2020, is projected to reach a revised size of US$505.6 Billion by 2027, growing at a CAGR of 8.1% over the analysis period 2020-2027. Recombinant Therapeutic Proteins, one of the segments analyzed in the report, is projected to record a 8.8% CAGR and reach US$187.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Blood & Blood components segment is readjusted to a revised 7.5% CAGR for the next 7-year period.The U.S. Market is Estimated at $86.5 Billion, While China is Forecast to Grow at 7.6% CAGRThe Biologics market in the U.S. is estimated at US$86.5 Billion in the year 2020. China, the world`s second largest economy, is fo..

Global Microbial Identification Market to Reach $3.4 Billion by 2027Amid the COVID-19 crisis, the global market for Microbial Identification estimated at US$2.4 Billion in the year 2020, is projected to reach a revised size of US$3.4 Billion by 2027, growing at a CAGR of 5.1% over the analysis period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record a 3.4% CAGR and reach US$1.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Consumables segment is readjusted to a revised 7% CAGR for the next 7-year period.The U.S. Market is Estimated at $707 Million, While China is Forecast to Grow at 4.8% CAGRThe Microbial Identification market in the U.S. is estimated at US$707 Million in the year 2020. China, the world`s second largest economy, is for..

Global Algae Market to Reach $1.2 Billion by 2027Amid the COVID-19 crisis, the global market for Algae estimated at US$782.9 Million in the year 2020, is projected to reach a revised size of US$1.2 Billion by 2027, growing at a CAGR of 6.2% over the analysis period 2020-2027. Open Pond Cultivation, one of the segments analyzed in the report, is projected to record a 6.2% CAGR and reach US$980.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Raceway Pond Cultivation segment is readjusted to a revised 5.6% CAGR for the next 7-year period.The U.S. Market is Estimated at $211.9 Million, While China is Forecast to Grow at 9.4% CAGRThe Algae market in the U.S. is estimated at US$211.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a project..

Global Rare Biomarkers Specimen Collection and Stabilization Market to Reach $48.5 Billion by 2027Amid the COVID-19 crisis, the global market for Rare Biomarkers Specimen Collection and Stabilization estimated at US$26.3 Billion in the year 2020, is projected to reach a revised size of US$48.5 Billion by 2027, growing at a CAGR of 9.2% over the analysis period 2020-2027. Circulating Cell Free DNA (ccfDNA), one of the segments analyzed in the report, is projected to record a 8.5% CAGR and reach US$19.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Circulating Tumor Cells (CTCs) segment is readjusted to a revised 9.6% CAGR for the next 7-year period.The U.S. Market is Estimated at $7.8 Billion, While China is Forecast to Grow at 8.6% CAGRThe Rare Biomarkers Specimen Collection..

Global Antibody Production Market to Reach $26.1 Billion by 2027Amid the COVID-19 crisis, the global market for Antibody Production estimated at US$11.7 Billion in the year 2020, is projected to reach a revised size of US$26.1 Billion by 2027, growing at aCAGR of 12.2% over the period 2020-2027. Monoclonal Antibody, one of the segments analyzed in the report, is projected to record 12.1% CAGR and reach US$20.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Polyclonal Antibody segment is readjusted to a revised 12.5% CAGR for the next 7-year period.The U.S. Market is Estimated at $3.2 Billion, While China is Forecast to Grow at 16% CAGRThe Antibody Production market in the U.S. is estimated at US$3.2 Billion in the year 2020. China, the world`s second largest economy, is forec..

Global Biopesticides Market to Reach $7.4 Billion by 2027Amid the COVID-19 crisis, the global market for Biopesticides estimated at US$3.3 Billion in the year 2020, is projected to reach a revised size of US$7.4 Billion by 2027, growing at aCAGR of 12.4% over the period 2020-2027. Microbials, one of the segments analyzed in the report, is projected to record 12.7% CAGR and reach US$5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bio-Rationals segment is readjusted to a revised 11.6% CAGR for the next 7-year period.The U.S. Market is Estimated at $961.9 Million, While China is Forecast to Grow at 11.9% CAGRThe Biopesticides market in the U.S. is estimated at US$961.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market s..

Global Mesenchymal Stem Cells (MSC) Market to Reach $229 Million by 2027Amid the COVID-19 crisis, the global market for Mesenchymal Stem Cells (MSC) estimated at US$172.9 Million in the year 2020, is projected to reach a revised size of US$229 Million by 2027, growing at a CAGR of 4.1% over the analysis period 2020-2027. Human MSC, one of the segments analyzed in the report, is projected to record a 4.6% CAGR and reach US$94.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Mouse MSC segment is readjusted to a revised 4% CAGR for the next 7-year period.The U.S. Market is Estimated at $50.9 Million, While China is Forecast to Grow at 3.9% CAGRThe Mesenchymal Stem Cells (MSC) market in the U.S. is estimated at US$50.9 Million in the year 2020. China, the world`s second largest ec..

Global Circulating Tumor Cell (CTC) Diagnostics Market to Reach $19 Billion by 2027Amid the COVID-19 crisis, the global market for Circulating Tumor Cell (CTC) Diagnostics estimated at US$6.2 Billion in the year 2020, is projected to reach a revised size of US$19 Billion by 2027, growing at a CAGR of 17.3% over the analysis period 2020-2027. CTC Enrichment Methods, one of the segments analyzed in the report, is projected to record a 17.8% CAGR and reach US$9.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the CTC Detection Methods segment is readjusted to a revised 17% CAGR for the next 7-year period.The U.S. Market is Estimated at $1.8 Billion, While China is Forecast to Grow at 16.6% CAGRThe Circulating Tumor Cell (CTC) Diagnostics market in the U.S. is estimated at US$1.8 Bill..

Global White Biotechnology Market to Reach $581 Billion by 2027Amid the COVID-19 crisis, the global market for White Biotechnology estimated at US$319.9 Billion in the year 2020, is projected to reach a revised size of US$581 Billion by 2027, growing at a CAGR of 8.9% over the analysis period 2020-2027. Biofuels, one of the segments analyzed in the report, is projected to record a 9.9% CAGR and reach US$233 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Biochemicals segment is readjusted to a revised 8.4% CAGR for the next 7-year period.The U.S. Market is Estimated at $86.3 Billion, While China is Forecast to Grow at 13.4% CAGRThe White Biotechnology market in the U.S. is estimated at US$86.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to r..

Global PEGylated Proteins Market to Reach $1.7 Billion by 2027Amid the COVID-19 crisis, the global market for PEGylated Proteins estimated at US$903.9 Million in the year 2020, is projected to reach a revised size of US$1.7 Billion by 2027, growing at aCAGR of 9.1% over the period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record 8.5% CAGR and reach US$1.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 10.4% CAGR for the next 7-year period.The U.S. Market is Estimated at $267.7 Million, While China is Forecast to Grow at 8.5% CAGRThe PEGylated Proteins market in the U.S. is estimated at US$267.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projec..

Global Stem Cells Market to Reach $15.1 Billion by 2027Amid the COVID-19 crisis, the global market for Stem Cells estimated at US$9.1 Billion in the year 2020, is projected to reach a revised size of US$15.1 Billion by 2027, growing at aCAGR of 7.4% over the period 2020-2027. Adult Stem Cells, one of the segments analyzed in the report, is projected to record 7.2% CAGR and reach US$12.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Other Product Types segment is readjusted to a revised 8.5% CAGR for the next 7-year period.The U.S. Market is Estimated at $2.7 Billion, While China is Forecast to Grow at 6.9% CAGRThe Stem Cells market in the U.S. is estimated at US$2.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market s..

Global Primary Cells Market to Reach $1.3 Billion by 2027Amid the COVID-19 crisis, the global market for Primary Cells estimated at US$775.5 Million in the year 2020, is projected to reach a revised size of US$1.3 Billion by 2027, growing at aCAGR of 7.1% over the period 2020-2027. Human Primary Cells, one of the segments analyzed in the report, is projected to record 7.5% CAGR and reach US$1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Animal Primary Cells segment is readjusted to a revised 5.7% CAGR for the next 7-year period.The U.S. Market is Estimated at $229.2 Million, While China is Forecast to Grow at 6.6% CAGRThe Primary Cells market in the U.S. is estimated at US$229.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a proj..

Global Tangential Flow Filtration Market to Reach $1.7 Billion by 2027Amid the COVID-19 crisis, the global market for Tangential Flow Filtration estimated at US$773 Million in the year 2020, is projected to reach a revised size of US$1.7 Billion by 2027, growing at a CAGR of 11.9% over the analysis period 2020-2027. Regenerated Cellulose, one of the segments analyzed in the report, is projected to record a 11.6% CAGR and reach US$648.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Polyethersulfone segment is readjusted to a revised 12.4% CAGR for the next 7-year period.The U.S. Market is Estimated at $228 Million, While China is Forecast to Grow at 11.4% CAGRThe Tangential Flow Filtration market in the U.S. is estimated at US$228 Million in the year 2020. China, the world`s s..

Global Automated Liquid Handling (ALH) Technologies Market to Reach $2.2 Billion by 2027Amid the COVID-19 crisis, the global market for Automated Liquid Handling (ALH) Technologies estimated at US$1.3 Billion in the year 2020, is projected to reach a revised size of US$2.2 Billion by 2027, growing at aCAGR of 8.1% over the period 2020-2027. Automated Liquid Handling Workstations, one of the segments analyzed in the report, is projected to record 8.1% CAGR and reach US$1.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents & Consumables segment is readjusted to a revised 8.1% CAGR for the next 7-year period.The U.S. Market is Estimated at $346.1 Million, While China is Forecast to Grow at 12.2% CAGRThe Automated Liquid Handling (ALH) Technologies market in the U.S. is est..

Global Competent Cells Market to Reach $3 Billion by 2027Amid the COVID-19 crisis, the global market for Competent Cells estimated at US$1.7 Billion in the year 2020, is projected to reach a revised size of US$3 Billion by 2027, growing at aCAGR of 8.8% over the period 2020-2027. Chemically Competent Cells, one of the segments analyzed in the report, is projected to record 8.5% CAGR and reach US$2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Electrocompetent Cells segment is readjusted to a revised 9.4% CAGR for the next 7-year period.The U.S. Market is Estimated at $490.7 Million, While China is Forecast to Grow at 8.2% CAGRThe Competent Cells market in the U.S. is estimated at US$490.7 Million in the year 2020. China, the world`s second largest economy, is forecast to rea..

Global Stem Cell Assay Market to Reach $4 Billion by 2027Amid the COVID-19 crisis, the global market for Stem Cell Assay estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$4 Billion by 2027, growing at a CAGR of 20.1% over the analysis period 2020-2027. Viability/Cytotoxicity, one of the segments analyzed in the report, is projected to record a 22.4% CAGR and reach US$1.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Isolation & Purification segment is readjusted to a revised 18.7% CAGR for the next 7-year period.The U.S. Market is Estimated at $332.4 Million, While China is Forecast to Grow at 19.2% CAGRThe Stem Cell Assay market in the U.S. is estimated at US$332.4 Million in the year 2020. China, the world`s second largest economy, is..

Global Biobanks Market to Reach $74.1 Billion by 2027Amid the COVID-19 crisis, the global market for Biobanks estimated at US$55.3 Billion in the year 2020, is projected to reach a revised size of US$74.1 Billion by 2027, growing at aCAGR of 4.3% over the period 2020-2027. Physical/Real Biobanks, one of the segments analyzed in the report, is projected to record 4.6% CAGR and reach US$48.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Virtual Biobanks segment is readjusted to a revised 3.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $16.3 Billion, While China is Forecast to Grow at 4.1% CAGRThe Biobanks market in the U.S. is estimated at US$16.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market s..

Global Metabolomics Market to Reach $3.5 Billion by 2027Amid the COVID-19 crisis, the global market for Metabolomics estimated at US$1.5 Billion in the year 2020, is projected to reach a revised size of US$3.5 Billion by 2027, growing at a CAGR of 12.8% over the analysis period 2020-2027. Bioanalytical Instruments & Equipment, one of the segments analyzed in the report, is projected to record a 11% CAGR and reach US$1.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Metabolomics Applications segment is readjusted to a revised 14.7% CAGR for the next 7-year period.The U.S. Market is Estimated at $443.3 Million, While China is Forecast to Grow at 12.4% CAGRThe Metabolomics market in the U.S. is estimated at US$443.3 Million in the year 2020. China, the world`s second largest eco..

Global Stem Cell Services Market to Reach $41.9 Billion by 2027Amid the COVID-19 crisis, the global market for Stem Cell Services estimated at US$17.7 Billion in the year 2020, is projected to reach a revised size of US$41.9 Billion by 2027, growing at a CAGR of 13.1% over the analysis period 2020-2027. Service Based, one of the segments analyzed in the report, is projected to record a 13.3% CAGR and reach US$15 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Therapeutic Application segment is readjusted to a revised 14% CAGR for the next 7-year period.The U.S. Market is Estimated at $5.2 Billion, While China is Forecast to Grow at 12.6% CAGRThe Stem Cell Services market in the U.S. is estimated at US$5.2 Billion in the year 2020. China, the world`s second largest economy, is f..

Global Molecular Breeding Market to Reach $7.1 Billion by 2027Amid the COVID-19 crisis, the global market for Molecular Breeding estimated at US$2.4 Billion in the year 2020, is projected to reach a revised size of US$7.1 Billion by 2027, growing at a CAGR of 16.7% over the analysis period 2020-2027. Marker-Assisted Selection (MAS), one of the segments analyzed in the report, is projected to record a 17.3% CAGR and reach US$2.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the QTL Mapping segment is readjusted to a revised 16.3% CAGR for the next 7-year period.The U.S. Market is Estimated at $711.2 Million, While China is Forecast to Grow at 16.1% CAGRThe Molecular Breeding market in the U.S. is estimated at US$711.2 Million in the year 2020. China, the world`s second largest eco..

Global Allogeneic Stem Cells Market to Reach $1.4 Billion by 2027Amid the COVID-19 crisis, the global market for Allogeneic Stem Cells estimated at US$666.3 Million in the year 2020, is projected to reach a revised size of US$1.4 Billion by 2027, growing at aCAGR of 10.6% over the period 2020-2027. Regenerative Therapy, one of the segments analyzed in the report, is projected to record 11.5% CAGR and reach US$869.6 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Drug Discovery & Development segment is readjusted to a revised 9.2% CAGR for the next 7-year period.The U.S. Market is Estimated at $179.9 Million, While China is Forecast to Grow at 14.2% CAGRThe Allogeneic Stem Cells market in the U.S. is estimated at US$179.9 Million in the year 2020. China, the world`s second larg..

Global Single-use Bioprocessing Market to Reach $10.4 Billion by 2027Amid the COVID-19 crisis, the global market for Single-use Bioprocessing estimated at US$3.4 Billion in the year 2020, is projected to reach a revised size of US$10.4 Billion by 2027, growing at a CAGR of 17.5% over the analysis period 2020-2027. Media Bags & Containers, one of the segments analyzed in the report, is projected to record a 18.5% CAGR and reach US$3.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Filtration Assemblies segment is readjusted to a revised 17.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $994.5 Million, While China is Forecast to Grow at 16.8% CAGRThe Single-use Bioprocessing market in the U.S. is estimated at US$994.5 Million in the year 2020. China, the worl..

Global Next Generation Sequencing (NGS) Data Analysis Market to Reach $1.4 Billion by 2027Amid the COVID-19 crisis, the global market for Next Generation Sequencing (NGS) Data Analysis estimated at US$638.8 Million in the year 2020, is projected to reach a revised size of US$1.4 Billion by 2027, growing at aCAGR of 12.2% over the period 2020-2027. Services, one of the segments analyzed in the report, is projected to record 12.5% CAGR and reach US$836.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Software segment is readjusted to a revised 11.7% CAGR for the next 7-year period.The U.S. Market is Estimated at $188.6 Million, While China is Forecast to Grow at 11.7% CAGRThe Next Generation Sequencing (NGS) Data Analysis market in the U.S. is estimated at US$188.6 Million in t..

Global RNA Analysis/Transcriptomics Market to Reach $8.7 Billion by 2027Amid the COVID-19 crisis, the global market for RNA Analysis/Transcriptomics estimated at US$3.7 Billion in the year 2020, is projected to reach a revised size of US$8.7 Billion by 2027, growing at a CAGR of 13.1% over the analysis period 2020-2027. Microarray, one of the segments analyzed in the report, is projected to record a 11.7% CAGR and reach US$754.9 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the PCR segment is readjusted to a revised 13.7% CAGR for the next 7-year period.The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 12.6% CAGRThe RNA Analysis/Transcriptomics market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world`s second largest econ..

Global Nutrigenomics Market to Reach $1.1 Billion by 2027Amid the COVID-19 crisis, the global market for Nutrigenomics estimated at US$390.2 Million in the year 2020, is projected to reach a revised size of US$1.1 Billion by 2027, growing at aCAGR of 16.1% over the period 2020-2027. Reagents & Kits, one of the segments analyzed in the report, is projected to record 16.4% CAGR and reach US$732.9 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 15.5% CAGR for the next 7-year period.The U.S. Market is Estimated at $115.5 Million, While China is Forecast to Grow at 15.4% CAGRThe Nutrigenomics market in the U.S. is estimated at US$115.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected ma..

Global Protein Binding Assays Market to Reach $514.1 Million by 2027Amid the COVID-19 crisis, the global market for Protein Binding Assays estimated at US$275.2 Million in the year 2020, is projected to reach a revised size of US$514.1 Million by 2027, growing at a CAGR of 9.3% over the analysis period 2020-2027. Equilibrium Dialysis, one of the segments analyzed in the report, is projected to record a 10% CAGR and reach US$205.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Ultrafiltration segment is readjusted to a revised 8.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $81.6 Million, While China is Forecast to Grow at 8.7% CAGRThe Protein Binding Assays market in the U.S. is estimated at US$81.6 Million in the year 2020. China, the world`s second large..

Global Biological Data Visualization Market to Reach $1.4 Billion by 2027Amid the COVID-19 crisis, the global market for Biological Data Visualization estimated at US$787.6 Million in the year 2020, is projected to reach a revised size of US$1.4 Billion by 2027, growing at a CAGR of 8.3% over the analysis period 2020-2027. Sequencing, one of the segments analyzed in the report, is projected to record a 8.4% CAGR and reach US$534.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Microscopy segment is readjusted to a revised 8.3% CAGR for the next 7-year period.The U.S. Market is Estimated at $212.7 Million, While China is Forecast to Grow at 12.5% CAGRThe Biological Data Visualization market in the U.S. is estimated at US$212.7 Million in the year 2020. China, the world`s second..

Global Biomaterials Market to Reach $315.9 Billion by 2027Amid the COVID-19 crisis, the global market for Biomaterials estimated at US$120.8 Billion in the year 2020, is projected to reach a revised size of US$315.9 Billion by 2027, growing at a CAGR of 14.7% over the analysis period 2020-2027. Polymers, one of the segments analyzed in the report, is projected to record a 15.1% CAGR and reach US$137.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Metallic segment is readjusted to a revised 14.4% CAGR for the next 7-year period.The U.S. Market is Estimated at $32.5 Billion, While China is Forecast to Grow at 19.2% CAGRThe Biomaterials market in the U.S. is estimated at US$32.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected..

Global Biopharmaceuticals Manufacturing Consumables Testing Market to Reach $797.1 Million by 2027Amid the COVID-19 crisis, the global market for Biopharmaceuticals Manufacturing Consumables Testing estimated at US$390.7 Million in the year 2020, is projected to reach a revised size of US$797.1 Million by 2027, growing at a CAGR of 10.7% over the analysis period 2020-2027. Compendial & Multi Compendial Laboratory Testing, one of the segments analyzed in the report, is projected to record a 10.3% CAGR and reach US$404.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Laboratory Testing segment is readjusted to a revised 10.9% CAGR for the next 7-year period.The U.S. Market is Estimated at $105.6 Million, While China is Forecast to Grow at 14.1% CAGRThe Biopharmaceuticals Manufac..

Global Polymerase Chain Reaction Market to Reach $11 Billion by 2027Amid the COVID-19 crisis, the global market for Polymerase Chain Reaction estimated at US$7.8 Billion in the year 2020, is projected to reach a revised size of US$11 Billion by 2027, growing at aCAGR of 5% over the period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record 4.9% CAGR and reach US$2.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents & Consumables segment is readjusted to a revised 5% CAGR for the next 7-year period.The U.S. Market is Estimated at $2.1 Billion, While China is Forecast to Grow at 7.7% CAGRThe Polymerase Chain Reaction market in the U.S. is estimated at US$2.1 Billion in the year 2020. China, the world`s second largest economy, is fore..

Global Plant Biotechnology Equipment Market to Reach $21.5 Billion by 2027Amid the COVID-19 crisis, the global market for Plant Biotechnology Equipment estimated at US$9.7 Billion in the year 2020, is projected to reach a revised size of US$21.5 Billion by 2027, growing at a CAGR of 12.1% over the analysis period 2020-2027. Breeding, one of the segments analyzed in the report, is projected to record a 11.8% CAGR and reach US$11.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Plant Research segment is readjusted to a revised 12.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $2.9 Billion, While China is Forecast to Grow at 11.6% CAGRThe Plant Biotechnology Equipment market in the U.S. is estimated at US$2.9 Billion in the year 2020. China, the world`s second..

Global Plant Breeding and CRISPR Plants Market to Reach $23.1 Billion by 2027Amid the COVID-19 crisis, the global market for Plant Breeding and CRISPR Plants estimated at US$9.6 Billion in the year 2020, is projected to reach a revised size of US$23.1 Billion by 2027, growing at aCAGR of 13.3% over the period 2020-2027. Conventional Breeding, one of the segments analyzed in the report, is projected to record 12.4% CAGR and reach US$12.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Biotechnological Method segment is readjusted to a revised 14.4% CAGR for the next 7-year period.The U.S. Market is Estimated at $2.8 Billion, While China is Forecast to Grow at 12.9% CAGRThe Plant Breeding and CRISPR Plants market in the U.S. is estimated at US$2.8 Billion in the year 2020. China..

Global Plant Genomics Market to Reach $12.2 Billion by 2027Amid the COVID-19 crisis, the global market for Plant Genomics estimated at US$7.7 Billion in the year 2020, is projected to reach a revised size of US$12.2 Billion by 2027, growing at a CAGR of 6.9% over the analysis period 2020-2027. Molecular Engineering, one of the segments analyzed in the report, is projected to record a 7.3% CAGR and reach US$6.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Genetic Engineering segment is readjusted to a revised 6.7% CAGR for the next 7-year period.The U.S. Market is Estimated at $2.3 Billion, While China is Forecast to Grow at 6.4% CAGRThe Plant Genomics market in the U.S. is estimated at US$2.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to..

Global Plasma Fractionation Market to Reach $31.9 Billion by 2027Amid the COVID-19 crisis, the global market for Plasma Fractionation estimated at US$22.1 Billion in the year 2020, is projected to reach a revised size of US$31.9 Billion by 2027, growing at a CAGR of 5.4% over the analysis period 2020-2027. Intravenous Immunoglobulins, one of the segments analyzed in the report, is projected to record a 5.8% CAGR and reach US$10.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Coagulation Factor Concentrates segment is readjusted to a revised 6.7% CAGR for the next 7-year period.The U.S. Market is Estimated at $6.5 Billion, While China is Forecast to Grow at 5% CAGRThe Plasma Fractionation market in the U.S. is estimated at US$6.5 Billion in the year 2020. China, the world`s se..

Global Nucleic Acid Labeling Market to Reach $2.8 Billion by 2027Amid the COVID-19 crisis, the global market for Nucleic Acid Labeling estimated at US$1.7 Billion in the year 2020, is projected to reach a revised size of US$2.8 Billion by 2027, growing at aCAGR of 7.3% over the period 2020-2027. Reagents & Kits, one of the segments analyzed in the report, is projected to record 7.8% CAGR and reach US$1.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 6.2% CAGR for the next 7-year period.The U.S. Market is Estimated at $508.6 Million, While China is Forecast to Grow at 6.8% CAGRThe Nucleic Acid Labeling market in the U.S. is estimated at US$508.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reac..

Global Cancer Stem Cells Market to Reach $1.7 Billion by 2027Amid the COVID-19 crisis, the global market for Cancer Stem Cells estimated at US$963 Million in the year 2020, is projected to reach a revised size of US$1.7 Billion by 2027, growing at aCAGR of 8.7% over the period 2020-2027. Stem Cell-based Cancer Therapy, one of the segments analyzed in the report, is projected to record 9.1% CAGR and reach US$1.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Targeted Cancerous Stem Cells segment is readjusted to a revised 8% CAGR for the next 7-year period.The U.S. Market is Estimated at $259.9 Million, While China is Forecast to Grow at 13.1% CAGRThe Cancer Stem Cells market in the U.S. is estimated at US$259.9 Million in the year 2020. China, the world`s second largest econo..

Global NGS-based RNA-seq Market to Reach $5.3 Billion by 2027Amid the COVID-19 crisis, the global market for NGS-based RNA-seq estimated at US$1.5 Billion in the year 2020, is projected to reach a revised size of US$5.3 Billion by 2027, growing at a CAGR of 19.9% over the analysis period 2020-2027. Sample Preparation, one of the segments analyzed in the report, is projected to record a 16% CAGR and reach US$998.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Sequencing Platforms & Consumables for RNA-Seq segment is readjusted to a revised 22.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $438 Million, While China is Forecast to Grow at 19.3% CAGRThe NGS-based RNA-seq market in the U.S. is estimated at US$438 Million in the year 2020. China, the world`s sec..

Global Neuroscience Antibodies and Assays Market to Reach $5.1 Billion by 2027Amid the COVID-19 crisis, the global market for Neuroscience Antibodies and Assays estimated at US$2.8 Billion in the year 2020, is projected to reach a revised size of US$5.1 Billion by 2027, growing at aCAGR of 8.8% over the period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record 9.2% CAGR and reach US$3.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 7.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $831.1 Million, While China is Forecast to Grow at 8.2% CAGRThe Neuroscience Antibodies and Assays market in the U.S. is estimated at US$831.1 Million in the year 2020. China, the world`s secon..

Global Cell Analysis Market to Reach $25.1 Billion by 2027Amid the COVID-19 crisis, the global market for Cell Analysis estimated at US$16.7 Billion in the year 2020, is projected to reach a revised size of US$25.1 Billion by 2027, growing at a CAGR of 6% over the analysis period 2020-2027. Flow Cytometry Products, one of the segments analyzed in the report, is projected to record a 6.6% CAGR and reach US$7.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the qPCR Products segment is readjusted to a revised 6.4% CAGR for the next 7-year period.The U.S. Market is Estimated at $4.5 Billion, While China is Forecast to Grow at 9.2% CAGRThe Cell Analysis market in the U.S. is estimated at US$4.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a..

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market to Reach $4.3 Billion by 2027Amid the COVID-19 crisis, the global market for Isothermal Nucleic Acid Amplification Technology (INAAT) estimated at US$2.2 Billion in the year 2020, is projected to reach a revised size of US$4.3 Billion by 2027, growing at a CAGR of 10.4% over the analysis period 2020-2027. Infectious Diseases, one of the segments analyzed in the report, is projected to record a 11.1% CAGR and reach US$2.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Blood Screening segment is readjusted to a revised 10.2% CAGR for the next 7-year period.The U.S. Market is Estimated at $642.4 Million, While China is Forecast to Grow at 9.7% CAGRThe Isothermal Nucleic Acid Amplification Technology (INAAT) ma..

Global Biodefense Market to Reach $19.5 Billion by 2027Amid the COVID-19 crisis, the global market for Biodefense estimated at US$13.5 Billion in the year 2020, is projected to reach a revised size of US$19.5 Billion by 2027, growing at aCAGR of 5.4% over the period 2020-2027. Vaccines, one of the segments analyzed in the report, is projected to record 5.6% CAGR and reach US$12.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Biothreat Detection Devices segment is readjusted to a revised 5.1% CAGR for the next 7-year period.The U.S. Market is Estimated at $4 Billion, While China is Forecast to Grow at 5% CAGRThe Biodefense market in the U.S. is estimated at US$4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size o..

Global Protective Cultures Market to Reach $490.5 Million by 2027Amid the COVID-19 crisis, the global market for Protective Cultures estimated at US$151 Million in the year 2020, is projected to reach a revised size of US$490.5 Million by 2027, growing at aCAGR of 18.3% over the period 2020-2027. Freeze-Dried, one of the segments analyzed in the report, is projected to record 18.9% CAGR and reach US$313 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Frozen segment is readjusted to a revised 17.3% CAGR for the next 7-year period.The U.S. Market is Estimated at $40.7 Million, While China is Forecast to Grow at 23.2% CAGRThe Protective Cultures market in the U.S. is estimated at US$40.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a p..

Global Protein Detection and Quantification Market to Reach $3.2 Billion by 2027Amid the COVID-19 crisis, the global market for Protein Detection and Quantification estimated at US$2 Billion in the year 2020, is projected to reach a revised size of US$3.2 Billion by 2027, growing at a CAGR of 7% over the analysis period 2020-2027. Kits & Reagents / Consumables, one of the segments analyzed in the report, is projected to record a 7.3% CAGR and reach US$2.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 6.1% CAGR for the next 7-year period.The U.S. Market is Estimated at $532 Million, While China is Forecast to Grow at 10.5% CAGRThe Protein Detection and Quantification market in the U.S. is estimated at US$532 Million in the year 20..

Global Protein Engineering Market to Reach $3.8 Billion by 2027Amid the COVID-19 crisis, the global market for Protein Engineering estimated at US$1.4 Billion in the year 2020, is projected to reach a revised size of US$3.8 Billion by 2027, growing at a CAGR of 14.7% over the analysis period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record a 14.1% CAGR and reach US$1.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents segment is readjusted to a revised 14.9% CAGR for the next 7-year period.The U.S. Market is Estimated at $389.9 Million, While China is Forecast to Grow at 19% CAGRThe Protein Engineering market in the U.S. is estimated at US$389.9 Million in the year 2020. China, the world`s second largest economy, is forecast to r..

Global CRISPR Technology Market to Reach $2.7 Billion by 2027Amid the COVID-19 crisis, the global market for CRISPR Technology estimated at US$680.3 Million in the year 2020, is projected to reach a revised size of US$2.7 Billion by 2027, growing at aCAGR of 21.8% over the period 2020-2027. Products, one of the segments analyzed in the report, is projected to record 21.1% CAGR and reach US$1.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 22.9% CAGR for the next 7-year period.The U.S. Market is Estimated at $203.2 Million, While China is Forecast to Grow at 21.4% CAGRThe CRISPR Technology market in the U.S. is estimated at US$203.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected..

Global Protein Extracts from Single Cell Protein and Other Conventional Sources Market to Reach $27.3 Billion by 2027Amid the COVID-19 crisis, the global market for Protein Extracts from Single Cell Protein and Other Conventional Sources estimated at US$17.1 Billion in the year 2020, is projected to reach a revised size of US$27.3 Billion by 2027, growing at a CAGR of 7% over the analysis period 2020-2027. Plant Protein Extract, one of the segments analyzed in the report, is projected to record a 6.5% CAGR and reach US$13.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Single Cell Proteins Microbial segment is readjusted to a revised 7.7% CAGR for the next 7-year period.The U.S. Market is Estimated at $5 Billion, While China is Forecast to Grow at 6.5% CAGRThe Protein Extract..

Global Protein Sequencing Market to Reach $1.2 Billion by 2027Amid the COVID-19 crisis, the global market for Protein Sequencing estimated at US$957.8 Million in the year 2020, is projected to reach a revised size of US$1.2 Billion by 2027, growing at aCAGR of 3.1% over the period 2020-2027. Mass Spectrometry, one of the segments analyzed in the report, is projected to record 2.9% CAGR and reach US$757.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Edman Degradation segment is readjusted to a revised 3.4% CAGR for the next 7-year period.The U.S. Market is Estimated at $281.5 Million, While China is Forecast to Grow at 3% CAGRThe Protein Sequencing market in the U.S. is estimated at US$281.5 Million in the year 2020. China, the world`s second largest economy, is forecast to..

Global Protein Stability Analysis Market to Reach $2.5 Billion by 2027Amid the COVID-19 crisis, the global market for Protein Stability Analysis estimated at US$1.4 Billion in the year 2020, is projected to reach a revised size of US$2.5 Billion by 2027, growing at a CAGR of 8.7% over the analysis period 2020-2027. Reagents & Assay Kits, one of the segments analyzed in the report, is projected to record a 9.6% CAGR and reach US$1.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 7.5% CAGR for the next 7-year period.The U.S. Market is Estimated at $379.4 Million, While China is Forecast to Grow at 13.2% CAGRThe Protein Stability Analysis market in the U.S. is estimated at US$379.4 Million in the year 2020. China, the world`s second..

Global Custom Antibody Market to Reach $552.1 Million by 2027Amid the COVID-19 crisis, the global market for Custom Antibody estimated at US$330.3 Million in the year 2020, is projected to reach a revised size of US$552.1 Million by 2027, growing at a CAGR of 7.6% over the analysis period 2020-2027. Monoclonal Antibodies, one of the segments analyzed in the report, is projected to record a 7.4% CAGR and reach US$208.1 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Polyclonal Antibodies segment is readjusted to a revised 7.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $89.3 Million, While China is Forecast to Grow at 11.5% CAGRThe Custom Antibody market in the U.S. is estimated at US$89.3 Million in the year 2020. China, the world`s second largest economy,..

Global Biophotonics Market to Reach $100.2 Billion by 2027Amid the COVID-19 crisis, the global market for Biophotonics estimated at US$51.1 Billion in the year 2020, is projected to reach a revised size of US$100.2 Billion by 2027, growing at a CAGR of 10.1% over the analysis period 2020-2027. Tests & Components, one of the segments analyzed in the report, is projected to record a 10.8% CAGR and reach US$20.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Medical Therapeutics segment is readjusted to a revised 9.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $15.2 Billion, While China is Forecast to Grow at 9.5% CAGRThe Biophotonics market in the U.S. is estimated at US$15.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to..

Global Commercial Biotechnology Separation Systems Market to Reach $31 Billion by 2027Amid the COVID-19 crisis, the global market for Commercial Biotechnology Separation Systems estimated at US$24.5 Billion in the year 2020, is projected to reach a revised size of US$31 Billion by 2027, growing at a CAGR of 3.4% over the analysis period 2020-2027. DNA Microarray, one of the segments analyzed in the report, is projected to record a 6.5% CAGR and reach US$7.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Liquid Chromatography segment is readjusted to a revised 2.4% CAGR for the next 7-year period.The U.S. Market is Estimated at $6.6 Billion, While China is Forecast to Grow at 6.8% CAGRThe Commercial Biotechnology Separation Systems market in the U.S. is estimated at US$6.6 Bill..

Global Recombinant DNA Technology Market to Reach $841.3 Million by 2027Amid the COVID-19 crisis, the global market for Recombinant DNA Technology estimated at US$609.8 Million in the year 2020, is projected to reach a revised size of US$841.3 Million by 2027, growing at aCAGR of 4.7% over the period 2020-2027. Medical, one of the segments analyzed in the report, is projected to record 5.2% CAGR and reach US$631.4 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Non-Medical segment is readjusted to a revised 3.4% CAGR for the next 7-year period.The U.S. Market is Estimated at $179.7 Million, While China is Forecast to Grow at 4.4% CAGRThe Recombinant DNA Technology market in the U.S. is estimated at US$179.7 Million in the year 2020. China, the world`s second largest economy, i..

Global DNA and Gene Chip Market to Reach $10.6 Billion by 2027Amid the COVID-19 crisis, the global market for DNA and Gene Chip estimated at US$5.4 Billion in the year 2020, is projected to reach a revised size of US$10.6 Billion by 2027, growing at aCAGR of 10% over the period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record 9.9% CAGR and reach US$6.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instrumentation segment is readjusted to a revised 10.2% CAGR for the next 7-year period.The U.S. Market is Estimated at $1.5 Billion, While China is Forecast to Grow at 13.3% CAGRThe DNA and Gene Chip market in the U.S. is estimated at US$1.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projec..

Global Apoptosis Market to Reach $6.9 Billion by 2027Amid the COVID-19 crisis, the global market for Apoptosis estimated at US$3.9 Billion in the year 2020, is projected to reach a revised size of US$6.9 Billion by 2027, growing at a CAGR of 8.6% over the analysis period 2020-2027. Assay Kits, one of the segments analyzed in the report, is projected to record a 8.9% CAGR and reach US$2.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents segment is readjusted to a revised 9.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 8.1% CAGRThe Apoptosis market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1...

Global BioImaging Technologies Market to Reach $64.4 Billion by 2027Amid the COVID-19 crisis, the global market for BioImaging Technologies estimated at US$41.1 Billion in the year 2020, is projected to reach a revised size of US$64.4 Billion by 2027, growing at aCAGR of 6.6% over the period 2020-2027. Medical Imaging, one of the segments analyzed in the report, is projected to record 7.4% CAGR and reach US$43.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Modular Imaging segment is readjusted to a revised 5.2% CAGR for the next 7-year period.The U.S. Market is Estimated at $12.1 Billion, While China is Forecast to Grow at 6.2% CAGRThe BioImaging Technologies market in the U.S. is estimated at US$12.1 Billion in the year 2020. China, the world`s second largest economy, is f..

Global Reporter Gene Assay Market to Reach $3.1 Billion by 2027Amid the COVID-19 crisis, the global market for Reporter Gene Assay estimated at US$1.7 Billion in the year 2020, is projected to reach a revised size of US$3.1 Billion by 2027, growing at aCAGR of 8.7% over the period 2020-2027. Assay Kits, one of the segments analyzed in the report, is projected to record 9.1% CAGR and reach US$2.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents segment is readjusted to a revised 7.6% CAGR for the next 7-year period.The U.S. Market is Estimated at $506.4 Million, While China is Forecast to Grow at 8.1% CAGRThe Reporter Gene Assay market in the U.S. is estimated at US$506.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a project..

Global Fermenters Market to Reach $1.9 Billion by 2027Amid the COVID-19 crisis, the global market for Fermenters estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$1.9 Billion by 2027, growing at a CAGR of 7.1% over the analysis period 2020-2027. Food, one of the segments analyzed in the report, is projected to record a 7.4% CAGR and reach US$600.7 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Beverages segment is readjusted to a revised 7.5% CAGR for the next 7-year period.The U.S. Market is Estimated at $320.4 Million, While China is Forecast to Grow at 10.8% CAGRThe Fermenters market in the U.S. is estimated at US$320.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of..

Global Genome Editing/Genome Engineering Market to Reach $10.3 Billion by 2027Amid the COVID-19 crisis, the global market for Genome Editing/Genome Engineering estimated at US$4.1 Billion in the year 2020, is projected to reach a revised size of US$10.3 Billion by 2027, growing at a CAGR of 14% over the analysis period 2020-2027. CRISPR, one of the segments analyzed in the report, is projected to record a 14.8% CAGR and reach US$4.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the TALEN segment is readjusted to a revised 14.2% CAGR for the next 7-year period.The U.S. Market is Estimated at $1.2 Billion, While China is Forecast to Grow at 13.4% CAGRThe Genome Editing/Genome Engineering market in the U.S. is estimated at US$1.2 Billion in the year 2020. China, the world`s second l..

Global Genomics Market to Reach $31.5 Billion by 2027Amid the COVID-19 crisis, the global market for Genomics estimated at US$17.5 Billion in the year 2020, is projected to reach a revised size of US$31.5 Billion by 2027, growing at a CAGR of 8.8% over the analysis period 2020-2027. Instruments/Systems, one of the segments analyzed in the report, is projected to record a 8.5% CAGR and reach US$9.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Consumables segment is readjusted to a revised 9.1% CAGR for the next 7-year period.The U.S. Market is Estimated at $5.2 Billion, While China is Forecast to Grow at 8.2% CAGRThe Genomics market in the U.S. is estimated at US$5.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market s..

Global Genotyping Market to Reach $46.4 Billion by 2027Amid the COVID-19 crisis, the global market for Genotyping estimated at US$13.9 Billion in the year 2020, is projected to reach a revised size of US$46.4 Billion by 2027, growing at a CAGR of 18.7% over the analysis period 2020-2027. Polymerase Chain Reaction (PCR), one of the segments analyzed in the report, is projected to record a 18.6% CAGR and reach US$16.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Sequencing segment is readjusted to a revised 19.6% CAGR for the next 7-year period.The U.S. Market is Estimated at $4.2 Billion, While China is Forecast to Grow at 18.4% CAGRThe Genotyping market in the U.S. is estimated at US$4.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reac..

Global Filter Integrity Testing Market to Reach $87.1 Million by 2027Amid the COVID-19 crisis, the global market for Filter Integrity Testing estimated at US$62.6 Million in the year 2020, is projected to reach a revised size of US$87.1 Million by 2027, growing at a CAGR of 4.8% over the analysis period 2020-2027. Diffusion, one of the segments analyzed in the report, is projected to record a 5.5% CAGR and reach US$37.9 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bubble Point segment is readjusted to a revised 4.7% CAGR for the next 7-year period.The U.S. Market is Estimated at $16.9 Million, While China is Forecast to Grow at 8% CAGRThe Filter Integrity Testing market in the U.S. is estimated at US$16.9 Million in the year 2020. China, the world`s second largest economy, i..

Global Expression Vectors Market to Reach $415.7 Million by 2027Amid the COVID-19 crisis, the global market for Expression Vectors estimated at US$291.4 Million in the year 2020, is projected to reach a revised size of US$415.7 Million by 2027, growing at a CAGR of 5.2% over the analysis period 2020-2027. Bacterial Expression Vectors, one of the segments analyzed in the report, is projected to record a 4.9% CAGR and reach US$228.6 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Mammalian Expression Vectors segment is readjusted to a revised 6% CAGR for the next 7-year period.The U.S. Market is Estimated at $85.9 Million, While China is Forecast to Grow at 5% CAGRThe Expression Vectors market in the U.S. is estimated at US$85.9 Million in the year 2020. China, the world`s second..

Global Environmental Control Systems Market to Reach $4.8 Billion by 2027Amid the COVID-19 crisis, the global market for Environmental Control Systems estimated at US$3.6 Billion in the year 2020, is projected to reach a revised size of US$4.8 Billion by 2027, growing at aCAGR of 4.2% over the period 2020-2027. Rotary, one of the segments analyzed in the report, is projected to record 4.8% CAGR and reach US$2.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Fixed segment is readjusted to a revised 3.7% CAGR for the next 7-year period.The U.S. Market is Estimated at $1.1 Billion, While China is Forecast to Grow at 3.9% CAGRThe Environmental Control Systems market in the U.S. is estimated at US$1.1 Billion in the year 2020. China, the world`s second largest economy, is forecast..

Global Next Generation Sequencing (NGS) Sample Preparation Market to Reach $6.4 Billion by 2027Amid the COVID-19 crisis, the global market for Next Generation Sequencing (NGS) Sample Preparation estimated at US$3.3 Billion in the year 2020, is projected to reach a revised size of US$6.4 Billion by 2027, growing at a CAGR of 9.8% over the analysis period 2020-2027. Semi-Automated Library Preparation, one of the segments analyzed in the report, is projected to record a 10.7% CAGR and reach US$2.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the NGS Library Preparation Kits segment is readjusted to a revised 9% CAGR for the next 7-year period.The U.S. Market is Estimated at $982.6 Million, While China is Forecast to Grow at 9.2% CAGRThe Next Generation Sequencing (NGS) Sample Prepa..

Global High-Resolution Melting Analysis Market to Reach $337.8 Million by 2027Amid the COVID-19 crisis, the global market for High-Resolution Melting Analysis estimated at US$276.2 Million in the year 2020, is projected to reach a revised size of US$337.8 Million by 2027, growing at a CAGR of 2.9% over the analysis period 2020-2027. SNP Genotyping, one of the segments analyzed in the report, is projected to record a 2.8% CAGR and reach US$92.4 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Mutation Discovery segment is readjusted to a revised 2.7% CAGR for the next 7-year period.The U.S. Market is Estimated at $81.2 Million, While China is Forecast to Grow at 2.8% CAGRThe High-Resolution Melting Analysis market in the U.S. is estimated at US$81.2 Million in the year 2020. Chin..

Global Short-Read Sequencing Market to Reach $20.4 Billion by 2027Amid the COVID-19 crisis, the global market for Short-Read Sequencing estimated at US$10.6 Billion in the year 2020, is projected to reach a revised size of US$20.4 Billion by 2027, growing at aCAGR of 9.9% over the period 2020-2027. Next-Generation Sequencing, one of the segments analyzed in the report, is projected to record 9.5% CAGR and reach US$13.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Sanger Sequencing segment is readjusted to a revised 10.6% CAGR for the next 7-year period.The U.S. Market is Estimated at $3.1 Billion, While China is Forecast to Grow at 9.3% CAGRThe Short-Read Sequencing market in the U.S. is estimated at US$3.1 Billion in the year 2020. China, the world`s second largest economy..

Global Fusion Proteins Market to Reach $29.1 Billion by 2027Amid the COVID-19 crisis, the global market for Fusion Proteins estimated at US$20.9 Billion in the year 2020, is projected to reach a revised size of US$29.1 Billion by 2027, growing at a CAGR of 4.8% over the analysis period 2020-2027. Metabolic Disorders, one of the segments analyzed in the report, is projected to record a 5.5% CAGR and reach US$8.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Immunological Disorders segment is readjusted to a revised 5.1% CAGR for the next 7-year period.The U.S. Market is Estimated at $6.2 Billion, While China is Forecast to Grow at 4.5% CAGRThe Fusion Proteins market in the U.S. is estimated at US$6.2 Billion in the year 2020. China, the world`s second largest economy, is forec..

Global Single-Cell Genome Sequencing Market to Reach $3.1 Billion by 2027Amid the COVID-19 crisis, the global market for Single-Cell Genome Sequencing estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$3.1 Billion by 2027, growing at aCAGR of 14% over the period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record 14.4% CAGR and reach US$1.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents segment is readjusted to a revised 13.5% CAGR for the next 7-year period.The U.S. Market is Estimated at $364 Million, While China is Forecast to Grow at 13.5% CAGRThe Single-Cell Genome Sequencing market in the U.S. is estimated at US$364 Million in the year 2020. China, the world`s second largest economy, i..

Global Drug Discovery Informatics Market to Reach $3.8 Billion by 2027Amid the COVID-19 crisis, the global market for Drug Discovery Informatics estimated at US$2 Billion in the year 2020, is projected to reach a revised size of US$3.8 Billion by 2027, growing at a CAGR of 9.8% over the analysis period 2020-2027. Sequencing & Target Data Analysis, one of the segments analyzed in the report, is projected to record a 11.5% CAGR and reach US$1.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Docking segment is readjusted to a revised 8.3% CAGR for the next 7-year period.The U.S. Market is Estimated at $591.8 Million, While China is Forecast to Grow at 9.2% CAGRThe Drug Discovery Informatics market in the U.S. is estimated at US$591.8 Million in the year 2020. China, the world`s s..

Global Spatial Genomics and Transcriptomics Market to Reach $275.8 Million by 2027Amid the COVID-19 crisis, the global market for Spatial Genomics and Transcriptomics estimated at US$170.7 Million in the year 2020, is projected to reach a revised size of US$275.8 Million by 2027, growing at a CAGR of 7.1% over the analysis period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record a 7.5% CAGR and reach US$143.4 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 6.4% CAGR for the next 7-year period.The U.S. Market is Estimated at $50.4 Million, While China is Forecast to Grow at 6.6% CAGRThe Spatial Genomics and Transcriptomics market in the U.S. is estimated at US$50.4 Million in the year 2020. C..

Global Stem Cell Manufacturing Market to Reach $16.5 Billion by 2027Amid the COVID-19 crisis, the global market for Stem Cell Manufacturing estimated at US$11.9 Billion in the year 2020, is projected to reach a revised size of US$16.5 Billion by 2027, growing at a CAGR of 4.9% over the analysis period 2020-2027. Culture Media, one of the segments analyzed in the report, is projected to record a 4.7% CAGR and reach US$6.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Consumables segment is readjusted to a revised 5.2% CAGR for the next 7-year period.The U.S. Market is Estimated at $3.5 Billion, While China is Forecast to Grow at 4.6% CAGRThe Stem Cell Manufacturing market in the U.S. is estimated at US$3.5 Billion in the year 2020. China, the world`s second largest economy, is..

Global Stem Cell Therapy Market to Reach $242.3 Million by 2027Amid the COVID-19 crisis, the global market for Stem Cell Therapy estimated at US$127.5 Million in the year 2020, is projected to reach a revised size of US$242.3 Million by 2027, growing at aCAGR of 9.6% over the period 2020-2027. Allogeneic, one of the segments analyzed in the report, is projected to record 9.9% CAGR and reach US$228.6 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Autologous segment is readjusted to a revised 5.6% CAGR for the next 7-year period.The U.S. Market is Estimated at $37.8 Million, While China is Forecast to Grow at 9% CAGRThe Stem Cell Therapy market in the U.S. is estimated at US$37.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a project..

Global Structural Biology and Molecular Modeling Techniques Market to Reach $17.2 Billion by 2027Amid the COVID-19 crisis, the global market for Structural Biology and Molecular Modeling Techniques estimated at US$5.7 Billion in the year 2020, is projected to reach a revised size of US$17.2 Billion by 2027, growing at a CAGR of 17.2% over the analysis period 2020-2027. SaaS & Standalone Modeling, one of the segments analyzed in the report, is projected to record a 18.2% CAGR and reach US$10.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Databases segment is readjusted to a revised 15.6% CAGR for the next 7-year period.The U.S. Market is Estimated at $1.5 Billion, While China is Forecast to Grow at 22.3% CAGRThe Structural Biology and Molecular Modeling Techniques market in t..

Global Computational Biology Market to Reach $9.2 Billion by 2027Amid the COVID-19 crisis, the global market for Computational Biology estimated at US$2.7 Billion in the year 2020, is projected to reach a revised size of US$9.2 Billion by 2027, growing at a CAGR of 19.2% over the analysis period 2020-2027. Cellular & Biological Simulation, one of the segments analyzed in the report, is projected to record a 18.1% CAGR and reach US$2.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Drug Discovery & Disease Modelling segment is readjusted to a revised 18.9% CAGR for the next 7-year period.The U.S. Market is Estimated at $798.4 Million, While China is Forecast to Grow at 18.5% CAGRThe Computational Biology market in the U.S. is estimated at US$798.4 Million in the year 2020. Chin..

Global Up-Regulated Protein Market to Reach $591.3 Million by 2027Amid the COVID-19 crisis, the global market for Up-Regulated Protein estimated at US$400.6 Million in the year 2020, is projected to reach a revised size of US$591.3 Million by 2027, growing at a CAGR of 5.7% over the analysis period 2020-2027. Diagnostic Labs, one of the segments analyzed in the report, is projected to record a 6.6% CAGR and reach US$217.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Outpatient Clinics segment is readjusted to a revised 5.7% CAGR for the next 7-year period.The U.S. Market is Estimated at $107.9 Million, While China is Forecast to Grow at 9.4% CAGRThe Up-Regulated Protein market in the U.S. is estimated at US$107.9 Million in the year 2020. China, the world`s second largest ec..

Global Life Science Tools Market to Reach $82.4 Billion by 2027Amid the COVID-19 crisis, the global market for Life Science Tools estimated at US$49.9 Billion in the year 2020, is projected to reach a revised size of US$82.4 Billion by 2027, growing at a CAGR of 7.4% over the analysis period 2020-2027. Cell Biology, one of the segments analyzed in the report, is projected to record a 7.3% CAGR and reach US$31.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Genomic segment is readjusted to a revised 7.5% CAGR for the next 7-year period.The U.S. Market is Estimated at $13.5 Billion, While China is Forecast to Grow at 11.2% CAGRThe Life Science Tools market in the U.S. is estimated at US$13.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to rea..

Global Assisted Reproductive Technology Market to Reach $40.8 Billion by 2026 Amid the COVID-19 crisis, the global market for Assisted Reproductive Technology estimated at US$24.7 Billion in the year 2020, is projected to reach a revised size of US$40.8 Billion by 2026, growing at a CAGR of 8.6% over the analysis period. In-Vitro Fertilization (IVF), one of the segments analyzed in the report, is projected to record a 8.5% CAGR and reach US$27 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Artificial Insemination-Intrauterine Insemination (AI-IUI) segment is readjusted to a revised 8.2% CAGR for the next 7-year period. The U.S. Market is Estimated at $8.1 Billion in 2021, While China is Forecast to Reach $7.1 Billion by 2026 The Assisted Reproductive Technology market in..

Global Live Cell Imaging Market to Reach $2.9 Billion by 2027Amid the COVID-19 crisis, the global market for Live Cell Imaging estimated at US$1.7 Billion in the year 2020, is projected to reach a revised size of US$2.9 Billion by 2027, growing at a CAGR of 7.5% over the analysis period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record a 8.1% CAGR and reach US$1.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 6.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $471.5 Million, While China is Forecast to Grow at 11.5% CAGRThe Live Cell Imaging market in the U.S. is estimated at US$471.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach..

Global Mammalian Polyclonal IgG Antibody Market to Reach $1.3 Billion by 2027Amid the COVID-19 crisis, the global market for Mammalian Polyclonal IgG Antibody estimated at US$912.3 Million in the year 2020, is projected to reach a revised size of US$1.3 Billion by 2027, growing at a CAGR of 4.9% over the analysis period 2020-2027. Metabolic Markers, one of the segments analyzed in the report, is projected to record a 5.5% CAGR and reach US$406.6 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Cardiac Markers segment is readjusted to a revised 5% CAGR for the next 7-year period.The U.S. Market is Estimated at $246.1 Million, While China is Forecast to Grow at 8% CAGRThe Mammalian Polyclonal IgG Antibody market in the U.S. is estimated at US$246.1 Million in the year 2020. China,..

Global Animal Genetics Market to Reach $7.4 Billion by 2027Amid the COVID-19 crisis, the global market for Animal Genetics estimated at US$4.6 Billion in the year 2020, is projected to reach a revised size of US$7.4 Billion by 2027, growing at a CAGR of 7% over the analysis period 2020-2027. Live Animals, one of the segments analyzed in the report, is projected to record a 7.6% CAGR and reach US$5.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Genetic Materials segment is readjusted to a revised 6.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 6.5% CAGRThe Animal Genetics market in the U.S. is estimated at US$1.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a pro..

Global Tissue Engineered Skin Substitutes Market to Reach $909 Million by 2027Amid the COVID-19 crisis, the global market for Tissue Engineered Skin Substitutes estimated at US$670.3 Million in the year 2020, is projected to reach a revised size of US$909 Million by 2027, growing at a CAGR of 4.4% over the analysis period 2020-2027. Biological, one of the segments analyzed in the report, is projected to record a 4.5% CAGR and reach US$406.9 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Synthetic segment is readjusted to a revised 4.6% CAGR for the next 7-year period.The U.S. Market is Estimated at $197.4 Million, While China is Forecast to Grow at 4.2% CAGRThe Tissue Engineered Skin Substitutes market in the U.S. is estimated at US$197.4 Million in the year 2020. China, the w..

Global Tissue Engineering Market to Reach $26.8 Billion by 2027Amid the COVID-19 crisis, the global market for Tissue Engineering estimated at US$11 Billion in the year 2020, is projected to reach a revised size of US$26.8 Billion by 2027, growing at a CAGR of 13.5% over the analysis period 2020-2027. Orthopedics, Musculoskeletal & Spine, one of the segments analyzed in the report, is projected to record a 12.1% CAGR and reach US$6.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Cardiology & Vascular segment is readjusted to a revised 15.7% CAGR for the next 7-year period.The U.S. Market is Estimated at $3.3 Billion, While China is Forecast to Grow at 13.1% CAGRThe Tissue Engineering market in the U.S. is estimated at US$3.3 Billion in the year 2020. China, the world`s second..

Global Tissue Expanders Market to Reach $1.5 Billion by 2027Amid the COVID-19 crisis, the global market for Tissue Expanders estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$1.5 Billion by 2027, growing at a CAGR of 4% over the analysis period 2020-2027. Anatomical, one of the segments analyzed in the report, is projected to record a 3.6% CAGR and reach US$566.9 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Round segment is readjusted to a revised 4.7% CAGR for the next 7-year period.The U.S. Market is Estimated at $335.5 Million, While China is Forecast to Grow at 3.8% CAGRThe Tissue Expanders market in the U.S. is estimated at US$335.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projecte..

Global Tissue Sectioning Market to Reach $763.2 Million by 2027Amid the COVID-19 crisis, the global market for Tissue Sectioning estimated at US$536.8 Million in the year 2020, is projected to reach a revised size of US$763.2 Million by 2027, growing at a CAGR of 5.2% over the analysis period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record a 5.5% CAGR and reach US$409.7 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Accessories & Consumables segment is readjusted to a revised 5.1% CAGR for the next 7-year period.The U.S. Market is Estimated at $158.2 Million, While China is Forecast to Grow at 4.8% CAGRThe Tissue Sectioning market in the U.S. is estimated at US$158.2 Million in the year 2020. China, the world`s second largest economy,..

Global Agrigenomics Market to Reach $18.4 Billion by 2026 Amid the COVID-19 crisis, the global market for Agrigenomics estimated at US$12.6 Billion in the year 2020, is projected to reach a revised size of US$18.4 Billion by 2026, growing at a CAGR of 6.4% over the analysis period. Crops, one of the segments analyzed in the report, is projected to record 6.6% CAGR and reach US$14.6 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Livestock segment is readjusted to a revised 5.8% CAGR for the next 7-year period. The U.S. Market is Estimated at $3.6 Billion in 2021, While China is Forecast to Reach $2.9 Billion by 2026 The Agrigenomics market in the U.S. is estimated at US$3.6 Billion in the year 2021. China, the world`s second largest economy, is forecast to reach a projecte..

Global Moving Bed Bioreactor (MBBR) Market to Reach $6.2 Billion by 2027Amid the COVID-19 crisis, the global market for Moving Bed Bioreactor (MBBR) estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$6.2 Billion by 2027, growing at a CAGR of 19% over the analysis period 2020-2027. Biochemical Oxygen Demand (BOD) / COD Removal, one of the segments analyzed in the report, is projected to record a 19.8% CAGR and reach US$3.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Nitrification/De-Nitrification segment is readjusted to a revised 18.5% CAGR for the next 7-year period.The U.S. Market is Estimated at $494.8 Million, While China is Forecast to Grow at 24.4% CAGRThe Moving Bed Bioreactor (MBBR) market in the U.S. is estimated at US$494.8 Mi..

Global Synthetic Cells Market to Reach $2.3 Billion by 2027Amid the COVID-19 crisis, the global market for Synthetic Cells estimated at US$590.3 Million in the year 2020, is projected to reach a revised size of US$2.3 Billion by 2027, growing at a CAGR of 21.8% over the analysis period 2020-2027. Pharmaceuticals & Diagnostics, one of the segments analyzed in the report, is projected to record a 23.9% CAGR and reach US$956.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Chemicals segment is readjusted to a revised 19.1% CAGR for the next 7-year period.The U.S. Market is Estimated at $158.8 Million, While China is Forecast to Grow at 27.6% CAGRThe Synthetic Cells market in the U.S. is estimated at US$158.8 Million in the year 2020. China, the world`s second largest economy, is..

Global Synthetic DNA Market to Reach $4.2 Billion by 2027Amid the COVID-19 crisis, the global market for Synthetic DNA estimated at US$1.3 Billion in the year 2020, is projected to reach a revised size of US$4.2 Billion by 2027, growing at a CAGR of 18% over the analysis period 2020-2027. Pharmaceuticals & Diagnostics, one of the segments analyzed in the report, is projected to record a 19.5% CAGR and reach US$1.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Chemicals segment is readjusted to a revised 16.6% CAGR for the next 7-year period.The U.S. Market is Estimated at $350.2 Million, While China is Forecast to Grow at 23.4% CAGRThe Synthetic DNA market in the U.S. is estimated at US$350.2 Million in the year 2020. China, the world`s second largest economy, is forecast to..

Global Synthetic Genes Market to Reach $8.8 Billion by 2027Amid the COVID-19 crisis, the global market for Synthetic Genes estimated at US$2.7 Billion in the year 2020, is projected to reach a revised size of US$8.8 Billion by 2027, growing at a CAGR of 18.2% over the analysis period 2020-2027. Pharmaceuticals & Diagnostics, one of the segments analyzed in the report, is projected to record a 18.7% CAGR and reach US$3.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Chemicals segment is readjusted to a revised 16.1% CAGR for the next 7-year period.The U.S. Market is Estimated at $735.5 Million, While China is Forecast to Grow at 23% CAGRThe Synthetic Genes market in the U.S. is estimated at US$735.5 Million in the year 2020. China, the world`s second largest economy, is foreca..

Global Cell Separation Technologies Market to Reach $5.2 Billion by 2027Amid the COVID-19 crisis, the global market for Cell Separation Technologies estimated at US$3 Billion in the year 2020, is projected to reach a revised size of US$5.2 Billion by 2027, growing at a CAGR of 8.1% over the analysis period 2020-2027. Research Laboratories & Institutes, one of the segments analyzed in the report, is projected to record a 7.7% CAGR and reach US$2.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Biotechnology & Pharmaceutical Industries segment is readjusted to a revised 9.1% CAGR for the next 7-year period.The U.S. Market is Estimated at $900.5 Million, While China is Forecast to Grow at 7.6% CAGRThe Cell Separation Technologies market in the U.S. is estimated at US$900.5 Millio..

Global Cell Viability Assays Market to Reach $4.7 Billion by 2027Amid the COVID-19 crisis, the global market for Cell Viability Assays estimated at US$2.9 Billion in the year 2020, is projected to reach a revised size of US$4.7 Billion by 2027, growing at aCAGR of 7% over the period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record 7.7% CAGR and reach US$3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 6% CAGR for the next 7-year period.The U.S. Market is Estimated at $864.6 Million, While China is Forecast to Grow at 6.5% CAGRThe Cell Viability Assays market in the U.S. is estimated at US$864.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a pro..

Global Cell Based Assays Market to Reach $24.2 Billion by 2027Amid the COVID-19 crisis, the global market for Cell Based Assays estimated at US$15.2 Billion in the year 2020, is projected to reach a revised size of US$24.2 Billion by 2027, growing at a CAGR of 6.9% over the analysis period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record a 7.3% CAGR and reach US$10.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 6.5% CAGR for the next 7-year period.The U.S. Market is Estimated at $4.5 Billion, While China is Forecast to Grow at 6.4% CAGRThe Cell Based Assays market in the U.S. is estimated at US$4.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach..

Global Cell Counting Market to Reach $12.9 Billion by 2027Amid the COVID-19 crisis, the global market for Cell Counting estimated at US$8.9 Billion in the year 2020, is projected to reach a revised size of US$12.9 Billion by 2027, growing at aCAGR of 5.4% over the period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record 4.5% CAGR and reach US$6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Consumables segment is readjusted to a revised 6.2% CAGR for the next 7-year period.The U.S. Market is Estimated at $2.6 Billion, While China is Forecast to Grow at 5% CAGRThe Cell Counting market in the U.S. is estimated at US$2.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US..

Global Cell Dissociation Market to Reach $546 Million by 2027Amid the COVID-19 crisis, the global market for Cell Dissociation estimated at US$245.2 Million in the year 2020, is projected to reach a revised size of US$546 Million by 2027, growing at a CAGR of 12.1% over the analysis period 2020-2027. Enzymatic Dissociation Products, one of the segments analyzed in the report, is projected to record a 12.8% CAGR and reach US$277.4 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Non-enzymatic Dissociation Products segment is readjusted to a revised 11.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $72.4 Million, While China is Forecast to Grow at 11.6% CAGRThe Cell Dissociation market in the U.S. is estimated at US$72.4 Million in the year 2020. China, the wor..

Global Cell Expansion Market to Reach $27.9 Billion by 2027Amid the COVID-19 crisis, the global market for Cell Expansion estimated at US$11.4 Billion in the year 2020, is projected to reach a revised size of US$27.9 Billion by 2027, growing at a CAGR of 13.6% over the analysis period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record a 12.8% CAGR and reach US$10 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Consumables segment is readjusted to a revised 14.3% CAGR for the next 7-year period.The U.S. Market is Estimated at $3.4 Billion, While China is Forecast to Grow at 13.2% CAGRThe Cell Expansion market in the U.S. is estimated at US$3.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a proje..

Global Cell Line Development Market to Reach $10.7 Billion by 2027Amid the COVID-19 crisis, the global market for Cell Line Development estimated at US$4.7 Billion in the year 2020, is projected to reach a revised size of US$10.7 Billion by 2027, growing at a CAGR of 12.3% over the analysis period 2020-2027. Equipment, one of the segments analyzed in the report, is projected to record a 12.5% CAGR and reach US$4.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Reagents & Media segment is readjusted to a revised 12.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 11.8% CAGRThe Cell Line Development market in the U.S. is estimated at US$1.4 Billion in the year 2020. China, the world`s second largest economy, is f..

Global Upstream Bioprocessing Market to Reach $13.3 Billion by 2027Amid the COVID-19 crisis, the global market for Upstream Bioprocessing estimated at US$5.9 Billion in the year 2020, is projected to reach a revised size of US$13.3 Billion by 2027, growing at a CAGR of 12.2% over the analysis period 2020-2027. Cell Culture, one of the segments analyzed in the report, is projected to record a 12.4% CAGR and reach US$6.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Media Preparation segment is readjusted to a revised 11.4% CAGR for the next 7-year period.The U.S. Market is Estimated at $1.8 Billion, While China is Forecast to Grow at 11.7% CAGRThe Upstream Bioprocessing market in the U.S. is estimated at US$1.8 Billion in the year 2020. China, the world`s second largest econom..

Global Biotechnology/Pharmaceutical Services Outsourcing Market to Reach $90.9 Billion by 2027Amid the COVID-19 crisis, the global market for Biotechnology/Pharmaceutical Services Outsourcing estimated at US$54.8 Billion in the year 2020, is projected to reach a revised size of US$90.9 Billion by 2027, growing at a CAGR of 7.5% over the analysis period 2020-2027. Consulting Services, one of the segments analyzed in the report, is projected to record a 9.2% CAGR and reach US$20.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Auditing & Assessment segment is readjusted to a revised 6.8% CAGR for the next 7-year period.The U.S. Market is Estimated at $14.8 Billion, While China is Forecast to Grow at 11.5% CAGRThe Biotechnology/Pharmaceutical Services Outsourcing market in the U...